neostigmine has been researched along with Milk-Alkali Syndrome in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Panettiere, FJ | 1 |
Lick, RF | 1 |
Endriss, R | 1 |
Hart, W | 1 |
Balser, D | 1 |
1 review available for neostigmine and Milk-Alkali Syndrome
Article | Year |
---|---|
The current management of malignancy. IV.-Cancer of the lung.
Topics: Adenocarcinoma; Adrenocorticotropic Hormone; Adult; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, S | 1975 |
1 other study available for neostigmine and Milk-Alkali Syndrome
Article | Year |
---|---|
[Influence of hypercalcemia on the simultaneously stimulated secretion in the vagus innervated main stomach and the vagus denervated Heidenhain pouch].
Topics: Animal Feed; Animals; Calcium; Denervation; Dogs; Female; Gastric Juice; Gastrins; Glucose; Histamin | 1967 |